Study of Phantom Limb Pain Using Peripheral Nerve and Spinal Cord Stimulation
Launched by ARTUR BIKTIMIROV · Dec 6, 2022
Trial Information
Current as of February 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purpose of this study is to evaluate the effectiveness of neuromodulation for relief of phantom limb pain (PLP) using peripheral nerve (PNS) and spinal cord stimulation (SCS) with implantable electrodes.
The study is conducted to collect information on the role of non-adaptive neuroplasticity and inhibitory descending antinociceptive influences, which determine the effect of peripheral nerve and spinal cord stimulation with implanted electrodes in patients with phantom limb pain as a result of amputation of the upper limb. Neuromodulation is a potential treatment option for chronic pai...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with implanted neuromodulation devices.
- • Amputation of the upper limb at the level of the forearm.
- • Age ranges from 18 to 65 years old.
- • The duration from the moment of amputation is from 6 months.
- • The presence of persistent chronic pain syndrome is from 4 to 10 points according to the Visual Analogue Scale
- • Absence of pregnancy at the time of implantation, confirmed by a pregnancy test.
- Exclusion Criteria:
- • The presence of severe somatic pathology
- • The presence of mental illness
- • The presence of a gross orthopedic deformity in the limb above the amputation level.
- • The presence of oncology.
- • The presence of epilepsy.
- • Complications after a traumatic brain injury or stroke.
- • Purulent - septic pathology.
- • Drug addiction.
- • Congenital malformation of the upper limb.
- • Any conditions that, according to the researcher, fall under the exclusion criteria.
About Artur Biktimirov
Artur Biktimirov is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a robust background in clinical development and a focus on innovative therapeutic solutions, Mr. Biktimirov leads initiatives that adhere to the highest standards of regulatory compliance and ethical practice. His expertise encompasses a wide range of therapeutic areas, reflecting a deep understanding of the complexities involved in clinical trials. Through strategic collaboration and a patient-centered approach, he aims to contribute significantly to the advancement of healthcare and the discovery of new treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vladivostok, Primorsky Krai, Russian Federation
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials